Publications by authors named "C V Albanese"

Germline inactivating mutations of the SLC25A1 gene contribute to various human disorders, including Velocardiofacial (VCFS), DiGeorge (DGS) syndromes and combined D/L-2-hydroxyglutaric aciduria (D/L-2HGA), a severe systemic disease characterized by the accumulation of 2-hydroxyglutaric acid (2HG). The mechanisms by which SLC25A1 loss leads to these syndromes remain largely unclear. Here, we describe a mouse model of SLC25A1 deficiency that mimics human VCFS/DGS and D/L-2HGA.

View Article and Find Full Text PDF

Objectives: This study aimed to compare the audiological benefits of a non-implantable wearable option for a bone conduction (BC) implant mounted on an arch (SoundArc) to those of traditional BC hearing aids (HAs) mounted on eyeglasses (BCHAs) in patients with moderate to severe conductive or mixed hearing loss.

Methods: A preliminary cross-sectional observational prospective cohort study was conducted in the Tertiary Audiological Department, University Hospital. Fourteen adults with conductive or mixed hearing loss (PTA at 0.

View Article and Find Full Text PDF

Herein, the integration of SnO nanoparticles with two Zn(II) porphyrins─Zn(II) 5,10,15,20-tetraphenylporphyrin (ZnTPP) and its perfluorinated counterpart, Zn(II) 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin (ZnTPPF)─was investigated for the sensing of gaseous acetone at 120 °C, adopting three Zn-porphyrin/SnO weight ratios (1:4, 1:32, and 1:64). For the first time, we were able to provide evidence of the correlation between the materials' conductivity and these nanocomposites' sensing performances, obtaining optimal results with a 1:32 ratio for ZnTPPF/SnO and showcasing a remarkable detection limit of 200 ppb together with a boosted sensing signal with respect to bare SnO. To delve deeper, the combination of experimental data with density functional theory calculations unveiled an electron-donating behavior of both porphyrins when interacting with tin dioxide semiconductor, especially for the nonfluorinated one.

View Article and Find Full Text PDF
Article Synopsis
  • Colorectal cancer (CRC) is a serious disease, causing many deaths and new cases every year in the U.S.
  • Successful treatment relies on removing all of the cancer cells during surgery, and using special imaging techniques can help doctors see the cancer better.
  • A new peptide called RC18 is being developed to help with imaging CRC during surgery by targeting a specific protein linked to the cancer.
View Article and Find Full Text PDF

Sodium-glucose cotransporter, type 2 inhibitors (SGLT2i) are emerging as the gold standard for treatment of type 2 diabetes (T2D) with renal protective benefits independent of glucose lowering. We took a high-level approach to evaluate the effects of the SGLT2i, empagliflozin (EMPA) on renal metabolism and function in a prediabetic model of metabolic syndrome. Male and female 12-wk-old TallyHo (TH) mice, and their closest genetic lean strain (Swiss-Webster, SW) were treated with a high-milk-fat diet (HMFD) plus/minus EMPA (@0.

View Article and Find Full Text PDF